Daily News Podcast

FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome


 

The FDA approved cannabidiol oral solution for the treatment of two rare pediatric seizure disorders. Also today, it’s a good idea to urge expectant parents to have a prenatal pediatrician visit, the Trump administration proposes changes to HHS and the FDA (view the complete proposal here), and after being approved for adults, the Eversense continuous glucose monitoring system is safe, durable, and accurate in children.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

TNF inhibitor linked to one-third drop in total mortality
MDedge Internal Medicine
Diabetic foot ulcer healing is predictable by WIfI stage scores
MDedge Internal Medicine
Impact of varicella vaccination on herpes zoster is not what was expected
MDedge Internal Medicine
Canakinumab cut gout attacks in CANTOS
MDedge Internal Medicine
MI risk prediction after noncardiac surgery simplified
MDedge Internal Medicine
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Internal Medicine
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Internal Medicine
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Internal Medicine
JAK inhibitor therapy promising for refractory dermatomyositis
MDedge Internal Medicine
Patients going without as insulin prices skyrocket
MDedge Internal Medicine